Autopsy report · NCT01798043

Impact of Septal Vs Apical Pacing on Right and Left Ventricular Performance

“Due to slow enrolment”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 month after it had already started.
• Ran for about 3 years before it stopped.
• 29 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Abbott Medical Devices

Sponsor type

Industry

Conditions

Heart Block; Sick Sinus Syndrome; Atrioventricular Block; Ventricular Dysfunction

Interventions

Cardiac MRI with pacemaker stimulation; Cardiac MRI with and without pacemaker stimulation

Participants

29

Sites

1

Countries

Switzerland

Trials that died the same way

• Effect of Establishing Functional Residual Capacity During Newborn Resuscitation on Oxygenation
  “Slow enrolment” (89% match in meaning)
• The Impact of Nebivolol Versus Metoprolol on Quality of Life
  “due to slow enrollment” (76% match in meaning)
• Integrative Analysis of Tumor Microenvironment and Optimization of Immunotherapy Duration in NSCL Cancer Patients
  “Enrolment was slowlier than expected.” (76% match in meaning)
• Sorafenib in First-line Treatment of Advanced B Child Hepatocellular Carcinoma
  “lack of enrolment” (72% match in meaning)
• Trial of Caffeine to Alleviate Dyspnea Related to Ticagrelor
  “Too low enrolment rate” (67% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.